Bonum Therapeutics

Seattle, WA · Founded 2021 · Privately Held (backing)

Developer of antibody-based therapeutics designed to enable targeted and regulated treatment of diseases. Bonum Therapeutics is based in Seattle, WA and was founded in 2021. Its last reported valuation was $130 million in Nov 2022. It has raised $127 million across 3 recorded rounds; the latest was a $26.9 million early-stage round in Apr 2026.

Last reported valuation
$130.0M
Oct 2026
Priced at
—
Total raised
$127.5M
Last round
Early Stage VC
Apr 2026

Who backs Bonum Therapeutics?

6 investors
InvestorType
Digitalis VenturesVenture capital
Vivo CapitalVenture capital
American Century Investments—
Codon Capital—
RiverVest Venture Partners—
Roche Venture Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Bonum Therapeutics investors

6 investors are on record for Bonum Therapeutics, including Digitalis Ventures, Vivo Capital, American Century Investments and Codon Capital. The early-stage round in Apr 2026 drew 8 investors.

Free account
More of Bonum Therapeutics with a free account
  • ·Watch Bonum Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Bonum Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View